An Update on the Role of Interim Restaging FDG-PET in Patients With Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

被引：17
|
作者：
Moskowitz, Craig H. [1 ]
Zelenetz, Andrew [1 ]
Schoder, Heiko [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2010年 / 8卷 / 03期
关键词：
Diffuse large B-cell lymphoma; Hodgkin lymphoma; stem cell transplantation; interim FDG-PET; POSITRON-EMISSION-TOMOGRAPHY; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; AGGRESSIVE LYMPHOMA; PROGNOSTIC VALUE; RESPONSE ASSESSMENT; PROGRESSION-FREE; CYCLES; DISEASE; RITUXIMAB;
D O I：
10.6004/jnccn.2010.0023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A significant amount of literature is available on treatment monitoring and response assessment in lymphoma using FDG-PET, yet confusion exists concerning the potential and limitations of FDG-PET for determining the presence of residual disease during chemotherapy (interim FDG-PET) This article reviews the role of interim FDG-PET in 3 important scenarios untreated diffuse large B-cell lymphoma, untreated Hodgkin lymphoma, and relapsed or refractory aggressive lymphoma in transplant-eligible patients, and provides recommendations on the use of this imaging modality in these settings (JNCCN 2010,8 347-352)
引用
收藏
页码：347 / 352
页数：6
相关论文
共 50 条
  • [31] PROGNOSTIC RELEVANCE OF FDG-PET IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA
    Kichigina, M.
    Mukhortova, O.
    Tumyan, G.
    Trofimova, O.
    Chekan, A.
    Larionova, V.
    Osmanov, D.
    HAEMATOLOGICA, 2013, 98 : 361 - 361
  • [32] Interim PET-CT in the management of diffuse large B-cell lymphoma
    Moskowitz, Craig H.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2012, : 397 - 401
  • [33] FDG-PET in Hodgkin lymphoma
    Kobe, C.
    Dietlein, M.
    Mauz-Koerholz, C.
    Engert, A.
    Borchmann, P.
    Sabri, O.
    Schober, O.
    Schicha, H.
    Kluge, R.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (06): : 235 - 238
  • [34] FDG-PET in Hodgkin Lymphoma
    Hutchings, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S16 - S16
  • [35] Automated Maximum Standardized Uptake Value Determination On FDG-PET for Diffuse Large B-Cell Lymphoma
    Kuker, R.
    Alderuccio, J.
    Rincon, A.
    Zhao, W.
    Moskowitz, C.
    Yang, F.
    MEDICAL PHYSICS, 2022, 49 (06) : E657 - E657
  • [36] Predictive Value of Interim FDG-PET/CT Interpreted withDeauville 5-point Score in Diffuse Large B-cell Lymphoma
    Zhang, Xu
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [37] Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma
    Hong, Junshik
    Lee, Yukyung
    Park, Yeonjeong
    Kim, Seog Gyun
    Hwang, Kyung Hoon
    Park, Soon Ho
    Jeong, Jihoon
    Kim, Kyung-Hee
    Ahn, Jeong Yeal
    Park, Sanghui
    Park, Jinny
    Lee, Jae Hoon
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 687 - 695
  • [38] Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma
    Junshik Hong
    Yukyung Lee
    Yeonjeong Park
    Seog Gyun Kim
    Kyung Hoon Hwang
    Soon Ho Park
    Jihoon Jeong
    Kyung-Hee Kim
    Jeong Yeal Ahn
    Sanghui Park
    Jinny Park
    Jae Hoon Lee
    Annals of Hematology, 2012, 91 : 687 - 695
  • [39] Prognostic value of interim 18F-FDG PET/CT in diffuse large B-cell lymphoma
    Zhitao Ying
    Xuejuan Wang
    Yuqin Song
    Wen Zheng
    Xiaopei Wang
    Yan Xie
    Ningjing Lin
    Meifeng Tu
    Lingyan Ping
    Weiping Liu
    Lijuan Deng
    Chen Zhang
    Zhi Yang
    Jun Zhu
    ChineseJournalofCancerResearch, 2013, 25 (01) : 95 - 101
  • [40] The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma
    Menguc, Meral Ulukoylu
    Mehtap, Ozgur
    Gorur, Gozde Daglioz
    Atesoglu, Elif Birtas
    Geduk, Ayfer
    Unal, Serkan
    Tarkun, Pinar
    Hacihanefioglu, Abdullah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : E922 - E927
12345